AEME |
anhydroecgonine methyl ester |
ATP |
adenosine triphosphate |
BBB |
blood brain barrier |
BE |
benzoylecgonine |
CE |
cocaethylene |
CNS |
central nervous system |
CUD |
cocaine use disorder |
CYP450 |
cytochrome P450 |
DAT |
dopamine transporter |
DSM-5 |
Diagnostics and Statistics Manual of Mental Disorders 5th edition |
EC |
ecgonine |
ED |
ecgonidine |
EDEE |
ecgonidine ethyl ester |
EEE |
ecgonine ethyl ester |
EMCDDA |
European Monitoring Centre for Drug and Drug Addiction |
EME |
ecgonine methyl ester |
FADM |
flavin adenine dinucleotide-containing monooxygenase |
GC-MS |
gas chromatography coupled with mass spectrometry |
GPx |
glutathione peroxidase |
GSH |
reduced glutathione |
hCE1
|
human carboxylesterase type 1 |
hCE2
|
human carboxylesterase type 2 |
HPLC |
high performance liquid chromatography |
LC-MS/MS |
liquid chromatography coupled with tandem mass spectrometry |
NAT |
noradrenaline transporter |
NBE |
norbenzoylecgonine |
NCE |
norcocaethylene |
NCOC |
norcocaine |
NCOC-NO•
|
orcocaine nitroxide |
NCOC-NO+
|
norcocaine nitrosonium |
NEDME |
norecgonidine methyl ester |
NEME |
norecgonine methyl ester |
NMDA |
N-methyl-D-aspartate |
N-OH-NCOC |
N-hydroxy-norcocaine |
(p-/m-)OH-BE |
(para-/meta-)hydroxybenzoylecgonine |
(p-/m-)OH-COC |
(para-/meta-)hydroxycocaine |
PChE |
pseudocholinesterase |
ROS |
reactive oxygen species |
SERT |
serotonin transporter |
SOD |
superoxide dismutase |
UPLC-MS/MS |
ultra-performance liquid chromatography coupled with tandem mass spectrometry |